#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Liposarcoma Adenovirus infection Selective polysaccharide antibody deficiency Lennox-Gastaut syndrome Ocular myasthenia Retinopathy proliferative Peritoneal mesothelioma malignant Medullary thyroid cancer Nasopharyngeal cancer Vulval cancer Behcet's syndrome Myeloid leukaemia Non-small cell lung cancer Acute myeloid leukaemia recurrent Anaplastic large cell lymphoma T- and null-cell types More trials…

    Learn about Rare Diseases

    Hypereosinophilic syndrome – Basic Information Prader-Willi syndrome – Treatment Myxofibrosarcoma Urea cycle disorder – Diagnostics Basal cell naevus syndrome – Trials in Disease Arterial tortuosity syndrome – Diagnostics CADASIL Mucous membrane pemphigoid – Basic Information Pemphigoid – Trials in Disease Arterial tortuosity syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Emraclidine Elamipretide Trihydrochloride Baclofen Niraparib Tosilate Monohydrate Aprepitant ALN-4324 Sacubitril Valsartan Ly3537982 Epirubicin Viltolarsen Rbd4059 Dolutegravir Azd3427 Tak-280 Citalopram Hydrochloride GSKVX000000030918 Triptorelin Acetate Naporafenib RIVASTIGMINE Anakinra More therapies…

    Learn about Your Condition

    Radiation skin injury Stevens-Johnson syndrome Gastric cancer stage IV Epstein-Barr virus infection Pelizaeus-Merzbacher disease Erectile dysfunction Bronchopulmonary dysplasia Palpitations Corneal graft rejection Oral lichen planus Corneal graft failure Mucopolysaccharidosis II Laryngeal leukoplakia Coronary artery bypass Pharyngeal cancer stage I More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Using Ultrasound with Perflubutane and Laxative for Detecting Crohn’s Disease in Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Perflubutane
    • Macrogol 3350
    • Sodium Hydrogen Carbonate
    Norway

  • Study on Managing Rheumatological Side Effects in Cancer Patients Using Fludeoxyglucose (18F) and Checkpoint Inhibitors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Fludeoxyglucose (18F)
    • Relatlimab
    • Ipilimumab
    The Netherlands

  • Study Comparing Progesterone and Ganirelix for Preventing LH Surge in Women Undergoing Ovarian Stimulation for Egg Donation

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Follitropin Alfa
    • Follitropin Alfa (Genetical Recombination)
    • Ganirelix
    Spain

  • Study comparing intranasal COVID-19 vaccine (LVT-001) with mRNA vaccine (bretovameran) as booster doses in healthy adults

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • LVT-001
    France

  • Study on Pain Relief Using Lidocaine and Sodium Chloride in Patients with Chronic Inflammatory Bowel Disease and Abdominal Pain

    Recruiting

    2 1 1
    Investigated Diseases:
    • Inflammatory bowel disease
    Investigated Drugs:
    • Lidocaine Hydrochloride Monohydrate
    • Sodium Chloride
    Belgium

  • Study on the Effects of Different Doses of Adenosine for Patients with Chronic Coronary Syndrome, with and without Heart Failure

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Myocardial ischaemia
    Investigated Drugs:
    • Gadoteric Acid
    • Adenosine
    Sweden
Previous Page
1 … 197 198 199 200 201 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!